Magangcong, Asnia P.
HRN: 27-44-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/13/2026
01/20/2026
IV
750mg
OD
UTI; Phlebitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes